Method of treating leukemia or leukemoid diseases
US4391802A · kind A · utility
34Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 1982 |
| Grant date | Jul 5, 1983 |
| Priority date | — |
| Expiry date | Mar 9, 2002 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of leukemia or leukemoid disease treatment by administration of a vitamin D derivative with a hydroxyl group at 1.alpha.-position is disclosed. It is believed that the vitamin D derivative with a hydroxyl group at 1.alpha.-position is capable of treating cancer through redifferentiation of cancer cells and that this capability is inherent in vitamin D derivatives with a hydroxyl group at 1.alpha.-position.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.